期刊文献+

华法林预防房颤患者血栓栓塞疗效观察 被引量:5

下载PDF
导出
摘要 目的探讨华法林对房颤患者血栓栓塞事件发生率的影响。方法 2009年2月~2011年3月治疗的房颤患者84例,随机分为华法林组(36例)、阿司匹林组(48例),分别给予华法林和阿司匹林治疗,观察两组血栓栓塞事件发生率并进行比较。结果经统计学分析,两组血栓栓塞事件发生率无统计学差异(P<0.01),两组不良反应发生率无统计学差异(P>0.05)。结论华法林和阿司匹林均可降低和防止血栓栓塞发生,可以避免严重出血等不良反应发生。
出处 《内科》 2012年第1期22-23,共2页 Internal Medicine
  • 相关文献

参考文献6

二级参考文献53

  • 1胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 2吴江,贾建平,崔丽英,等.神经病学[M].第1版.北京:人民卫生出版社,2008:165-166.
  • 3Singer DE,Albers GW,Dalen JE,et al.Antithrombotic Therspy in Atrial Fibrillation The 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].CHEST,2004,126:429S-456S.
  • 4Michael DE,Jody AL.Preventing stroke in patients with a trial fibrillation[J].JAMA,1999,281:1830.
  • 5Hodgson-Zingman DM,Karst ML, Zingman LV, et al. Atrial natri- uretic peptide frameshift mutation in familial atrial fibriltation[J].N Engl J Med,2008,3(59) : 158.
  • 6Zhang X, Chen S,Yoo S,et al.Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death[J]. Cell, 2008,135 : 1017.
  • 7Michael H, Gollob, M.D.Somatic mutations in the connexin 40 gene (GJAS) in atrial fibrillation[J].N Engl J Med, 2006,354:2677.
  • 8Juang JM ,Chern YR ,Tsai CT,et al.The association of human con- nexin 40 genetic polymorphisms with atrial fibrillation[J]. Int J Car- dial, 2007,116:107.
  • 9Alex V.Postma A Gain-of-Function TBX5 Mutation Is Associated With Atypical Hoh-Oram Syndrome and Paroxysmal Atrial Fibrilla- tion[J].Circ Res, 2008,102:1433.
  • 10Darbar D, Motsinger A A, Ritchie MD,et al..Polymorphism modu- lates symptomatic response to antiarrhythmie drug therapy in pa- tients with lone atrial fibrillation[J].Heart Rhythm, 2007 ,.4:743.

共引文献36

同被引文献39

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1398
  • 2胡曙云.心房纤颤146例患者抗凝状况分析[J].内科,2007,2(3):358-359. 被引量:1
  • 3郑策,梅丹.影响华法林抗凝血作用的有关因素[J].药物不良反应杂志,2007,9(4):256-261. 被引量:102
  • 4雷运森.华法林在心房颤动患者中的临床应用[J].医药前沿,2013,(10):203-204.
  • 5张迎军,王悦喜,任保军,阿荣.预防非瓣膜性房颤的血栓栓塞研究[J].内蒙古医学院学报.2009(03)
  • 6N.A. Mark Estes,Jonathan L. Halperin,Hugh Calkins,Michael D. Ezekowitz,Paul Gitman,Alan S. Go,Robert L. McNamara,Joseph V. Messer,James L. Ritchie,Sam J.W. Romeo,Albert L. Waldo,D. George Wyse.ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter[J].Journal of the American College of Cardiology.2008(8)
  • 7Tetsu Watanabe,Yasuchika Takeishi,Osamu Hirono,Makoto Itoh,Motoyuki Matsui,Kazuharu Nakamura,Yoshiaki Tamada,Isao Kubota.C-Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation[J].Heart and Vessels.2005(2)
  • 8Hiromi Shimizu,Yo Murakami,Shin-ichi Inoue,Yoko Ohta,Ko Nakamura,Harumi Katoh,Takeshi Sakne,Nobuyuki Takahashi,Shuzo Ohata,Takashi Sugamori,Yutaka Ishibashi,Toshio Shimada.High Plasma Brain Natriuretic Polypeptide Level as a Marker of Risk for Thromboembolism in Patients With Nonvalvular Atrial Fibrillation[J].Stroke: Journal of the American Heart Association.2002(4)
  • 9Anders Roijer,Carl J. Meurling,J. Eskilsson,B. Olsson.Left Atrial Appendage Outflow Velocity Index is Superior to Conventional Criteria for Prediction of Maintenance of Sinus Rhythm after Cardioversion. An Echocardiographic Study in Patients with Atrial Fibrillation of a Few Months’ Duration[J].Scandinavian Cardiovascular Journal.2001(2)
  • 10Hans-Christoph Diener,John Eikelboom,Stuart J Connolly,Campbell D Joyner,Robert G Hart,Gregory YH Lip,Martin O’Donnell,Stefan H Hohnloser,Graeme J Hankey,Olga Shestakovska,Salim Yusuf.Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial[J]. Lancet Neurology . 2012 (3)

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部